Health

Between 5 and 10 million people could lose Medicaid coverage in 2028 due to changes from the One Big Beautiful Bill Act, depending on the steps states take to mitigate …

Deciding which AI tools to adopt isn’t about hype — it’s about evidence and real-world impact, according to Rebecca Mishuris, chief health information officer and vice president of digital at …

In 2006, Fujifilm faced an existential crisis when people stopped buying camera film in favor of digital cameras. Almost overnight sales crumbled. The company made the decision to do a …

Red and near-infrared light therapy, referred to as photobiomodulation or PBM by the medical community, has recently moved from clinical environments and into the consumer health industry. Devices are now …

A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a certain inherited immunodeficiency so severe that many babies do not …

Everlywell, an at-home lab testing company, is partnering with AI-powered gut microbiome company Jona to bring a gut microbiome test to consumers nationwide. Everlywell is a direct-to-consumer company selling tests …

Health systems should use data to identify problems before buying AI tools, according to Arcadia CEO Michael Meucci. The market is flooded with vendors pitching AI solutions — but instead …

The pressure facing healthcare leaders has never been higher, from workforce challenges and Medicaid cuts to rising tariff uncertainty. In fact, under the One Big Beautiful Bill Act (OBBBA), tens …

They’re a great way to bring screenings, diagnostics and preventive care services to the people who need them. However, launching a mobile clinic program requires a partner that understands medical …

For years, robotic bronchoscopy was confined mainly to elite academic centers and referral hospitals that possessed the budgets, staffing, and infrastructure required to support early-generation systems. That era is ending. …